- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04077229
Piloting Text Messages to Promote Positive Affect and Physical Activity
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a single-arm study of text messaging in post-ACS patients. The convenience sample for this pilot study will be enrolled from two sources: (a) participants prospectively enrolled from inpatient cardiac units at MGH admitted for an ACS, and (b) participants in prior post-ACS studies performed with the investigators' team.
A total of 28 intervention text messages (1/day for 4 weeks) will be sent to participants following the baseline assessment. After each message is sent, participants will receive a second text message asking them to rate the utility of the message, and this rating will be used by a machine learning algorithm to select subsequent messages. This will ensure that, over time, participants will receive messages that they are more likely to find useful.
In the first part of the study, participants will receive 28 fixed text messages that alternate between physical activity and positive psychology messages. In the second part of the study, participants will receive 14 fixed text messages that range in topics from positive psychology to physical activity, diet, and medication adherence. In the second part of the study, participants will first receive a set of 14 pre-selected daily messages that contain a broad range of attributes to allow sufficient participant feedback to clearly identify preferences. After the first 14 messages, new messages will be selected based on the prior preferences of participants.
The messages will be sent using the Twilio texting program used by REDCap, which also uses Amazon Web Services. Twilio allows software developers to programmatically make and receive phone calls and send and receive text messages using its web service. The investigators have purchased a Twilio account to allow messages to come from an anonymous phone number rather than the phone of a study staff member.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Jeff Huffman
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Prior acute coronary syndrome.
Acute myocardial infarction (MI):
- Elevation of cardiac biomarkers (cardiac troponin T) in addition to one or more of the following:
- symptoms of ischemia (e.g., acute chest pain)
- ischemic changes on electrocardiogram
- imaging evidence of new loss of viable myocardium or new regional wall motion abnormality.
Unstable angina (UA):
- crescendo angina
- new onset (within 1 month) angina with minimal exertion
- angina with minimal exertion or at rest.
- Ability to receive text messages via cellular phone.
Exclusion Criteria:
- A periprocedural ACS
- Terminal illness
- An unrelated condition limiting physical activity
- An inability to communicate in English, or
- cognitive disorder assessed by 6-item cognitive screen
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
A total of 28 intervention text messages (1/day for 4 weeks) will be sent to participants following the baseline self-report assessment.
After each message is sent, participants will receive a second text message asking them to rate the utility of the message.
Following the 4-week intervention, participants will complete the same self-report assessments as in the baseline assessment (via phone) and will provide feedback about the program.
Finally, 4 weeks later (at 8 weeks), participants will repeat the self-report questionnaires by phone.
|
Participants will receive a combination of messages promoting both psychological well-being and education /support around health behavior adherence, such as physical activity or diet.
In the first part of the study, participants will receive 28 fixed text messages that alternate between physical activity and PP (Positive Psychology) messages.
In the second part of the study, participants will first receive a set of 14 pre-selected daily messages that contain a broad range of attributes to allow sufficient participant feedback to clearly identify preferences.
After the first 14 messages, new messages will be selected based on the prior preferences of participants.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of text messages successfully delivered to participants
Time Frame: 4 weeks
|
Feasibility will be measured by calculating the percentage of text messages successfully delivered to participants.
|
4 weeks
|
|
Participant burden
Time Frame: 4 weeks
|
Mean ratings of the intervention's burden, as reported by participants on a 0-10 Likert-type scale (0= not burdensome at all; 10= extremely burdensome).
|
4 weeks
|
|
Self-reported utility of the intervention
Time Frame: 4 weeks
|
Mean ratings of the intervention's utility, as reported by participants on a 0-10 Likert-type scale (0= not helpful at all; 10= extremely helpful).
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Positive Affect at 4 weeks
Time Frame: Change in positive affect from baseline to 4 weeks
|
Pre-post changes in level of positive affect on a 0-10 Likert scale (0=not happy at all, 10-extremely happy).
Higher values represent a better outcome.
|
Change in positive affect from baseline to 4 weeks
|
|
Change in Positive Affect at 8 weeks
Time Frame: Change in positive affect from baseline to 8 weeks
|
Pre-post changes in level of positive affect on a 0-10 Likert scale (0=not happy at all, 10-extremely happy).
Higher values represent a better outcome.
|
Change in positive affect from baseline to 8 weeks
|
|
Change in Optimism at 4 weeks
Time Frame: Change in optimism from baseline to 4 weeks
|
Pre-post changes in level of optimism on a 0-10 Likert scale (0=not optimistic at all, 10-extremely optimistic).
Higher values represent a better outcome.
|
Change in optimism from baseline to 4 weeks
|
|
Change in Optimism at 8 weeks
Time Frame: Change in optimism from baseline to 8 weeks
|
Pre-post changes in level of optimism on a 0-10 Likert scale (0=not optimistic at all, 10-extremely optimistic).
Higher values represent a better outcome.
|
Change in optimism from baseline to 8 weeks
|
|
Change in Determination at 4 weeks
Time Frame: Change in determination from baseline to 4 weeks
|
Pre-post changes in level of determination on a 0-10 Likert scale (0=not determined at all, 10= extremely determined).
Higher values represent a better outcome.
|
Change in determination from baseline to 4 weeks
|
|
Change in Determination at 8 weeks
Time Frame: Change in determination from baseline to 8 weeks
|
Pre-post changes in level of determination on a 0-10 Likert scale (0=not determined at all, 10= extremely determined).
Higher values represent a better outcome.
|
Change in determination from baseline to 8 weeks
|
|
Change in Depression at 4 weeks
Time Frame: Change in depression from baseline to 4 weeks
|
Pre-post changes in level of depression on a 0-10 Likert scale (0=not depressed at all, 10= extremely depressed).
Higher values represent a better outcome.
|
Change in depression from baseline to 4 weeks
|
|
Change in Depression at 8 weeks
Time Frame: Change in depression from baseline to 8 weeks
|
Pre-post changes in level of depression on a 0-10 Likert scale (0=not depressed at all, 10= extremely depressed).
Higher values represent a better outcome.
|
Change in depression from baseline to 8 weeks
|
|
Change in Anxiety at 4 weeks
Time Frame: Change in anxiety from baseline to 4 weeks
|
Pre-post changes in level of anxiety on a 0-10 Likert scale (0=not anxious at all, 10= extremely anxious).
Higher values represent a better outcome.
|
Change in anxiety from baseline to 4 weeks
|
|
Change in Anxiety at 8 weeks
Time Frame: Change in anxiety from baseline to 8 weeks
|
Pre-post changes in level of anxiety on a 0-10 Likert scale (0=not anxious at all, 10= extremely anxious).
Higher values represent a better outcome.
|
Change in anxiety from baseline to 8 weeks
|
|
Change in Self-reported physical activity at 4 weeks
Time Frame: Change in self-reported physical activity from baseline to 4 weeks
|
Pre-post changes in level of physical activity. Participants will complete a two-item assessment for physical activity that has been validated and used in thousands of patients in the Kaiser Permanente system. We will record completion of moderate activity in number of minutes of activity/week. The items are: In the past 4 weeks, how many days/week did you engage in moderate or greater physical activity? On those days, how many minutes do you engage in activity at this level? These two measures are multiplied to arrive at the average min/week of moderate or greater physical activity. |
Change in self-reported physical activity from baseline to 4 weeks
|
|
Change in Self-reported physical activity at 8 weeks
Time Frame: Change in self-reported physical activity from baseline to 8 weeks
|
Pre-post changes in level of physical activity. Participants will complete a two-item assessment for physical activity that has been validated and used in thousands of patients in the Kaiser Permanente system. We will record completion of moderate activity in number of minutes of activity/week. The items are: In the past 4 weeks, how many days/week did you engage in moderate or greater physical activity? On those days, how many minutes do you engage in activity at this level? These two measures are multiplied to arrive at the average min/week of moderate or greater physical activity. |
Change in self-reported physical activity from baseline to 8 weeks
|
|
Change in Self-reported dietary adherence at 4 weeks
Time Frame: Change in dietary adherence from baseline to 4 weeks
|
Pre-post changes in level of self-reported dietary adherence.
Participants will be asked a single item about self-reported dietary adherence, adapted from the Medical Outcomes Study Specific Adherence Scale.
"In the last month, how often have you followed a low-fat, low-salt, or other diet as prescribed by your treatment team?" Choices will include "None of the time (1)," "A little of the time (2)," "Some of the time (3)," "A good bit of the time (4)," "most of the time (5)," and "all of the time (6)."
Higher values represent a better outcome.
|
Change in dietary adherence from baseline to 4 weeks
|
|
Change in Self-reported dietary adherence at 8 weeks
Time Frame: Change in dietary adherence from baseline to 8 weeks
|
Pre-post changes in level of self-reported dietary adherence.
Participants will be asked a single item about self-reported dietary adherence, adapted from the Medical Outcomes Study Specific Adherence Scale.
"In the last month, how often have you followed a low-fat, low-salt, or other diet as prescribed by your treatment team?" Choices will include "None of the time (1)," "A little of the time (2)," "Some of the time (3)," "A good bit of the time (4)," "most of the time (5)," and "all of the time (6)."
Higher values represent a better outcome.
|
Change in dietary adherence from baseline to 8 weeks
|
|
Change in Self-reported health/function at 4 weeks
Time Frame: Change in self-reported health/function from baseline to 4 weeks
|
Participants will be asked a single item about self-reported health: "In general, how would you rate your health today" with the possible choices being "very good" (1), "good" (2), "moderate" (3), "bad" (4) or "very bad" (5).
This scale is a robust predictor of mortality and correlates strongly with other objective health indicators.
Lower values represent a better outcome.
|
Change in self-reported health/function from baseline to 4 weeks
|
|
Change in Self-reported health/function at 8 weeks
Time Frame: Change in self-reported health/function from baseline to 8 weeks
|
Participants will be asked a single item about self-reported health: "In general, how would you rate your health today" with the possible choices being "very good" (1), "good" (2), "moderate" (3), "bad" (4) or "very bad" (5).
This scale is a robust predictor of mortality and correlates strongly with other objective health indicators.
Lower values represent a better outcome.
|
Change in self-reported health/function from baseline to 8 weeks
|
|
Change in self-reported physical function at 4 weeks
Time Frame: Change in self-reported physical function from baseline to 4 weeks
|
This will be assessed with the Duke Activity Status Index (DASI).
The DASI contains 12 items that inquire about activities of daily living (e.g., bathing), basic physical activity (e.g., walking, climbing stairs), and more strenuous physical function (e.g., vigorous sports) to gauge overall functional capacity.
Higher values represent a better outcome (range 0-58.2).
|
Change in self-reported physical function from baseline to 4 weeks
|
|
Change in self-reported physical function at 8 weeks
Time Frame: Change in self-reported physical function from baseline to 8 weeks
|
This will be assessed with the Duke Activity Status Index (DASI).
The DASI contains 12 items that inquire about activities of daily living (e.g., bathing), basic physical activity (e.g., walking, climbing stairs), and more strenuous physical function (e.g., vigorous sports) to gauge overall functional capacity.
Higher values represent a better outcome (range 0-58.2).
|
Change in self-reported physical function from baseline to 8 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016P001472
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Coronary Syndrome
-
Chulalongkorn UniversityCompletedCKD | Coronary Angiography (CAG) | ACS (Acute Coronary Syndrome)
-
Shenyang Northern HospitalNot yet recruitingSGLT2 Inhibitors | ACS (Acute Coronary Syndrome)China
-
Mahidol UniversityNot yet recruitingCoronary Artery Disease | Acute Coronary Syndrome/ Myocardial InfarctionThailand
-
Aarhus University Hospital SkejbyAbbottEnrolling by invitationIschemic Heart Disease | Ischemic Coronary Artery Disease | ACS (Acute Coronary Syndrome)Denmark, Belgium, Finland, Sweden, Switzerland, Germany, Latvia, Norway, United Kingdom, Estonia, Netherlands, Italy
-
Yonsei UniversityRecruitingCoronary Artery Disease, Acute Coronary SyndromeKorea, Republic of
-
Heart Care FoundationNovartis Farma S.p.A.Not yet recruitingAcute Coronary Syndromes | Chronic Coronary SyndromesItaly
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
Xiling QiRecruitingHF - Heart Failure | ACS (Acute Coronary Syndrome)China
-
Shenyang Northern HospitalChinese Academy of Medical Sciences, Fuwai HospitalNot yet recruitingCoronary Artery Disease (CAD) | Acute Coronary Syndrome (ACS) | High Bleeding Risk(HBR)China
-
SUK MIN SEOBoston Scientific Korea Co. LtdRecruitingAcute Coronary Syndromes (ACS)South Korea
Clinical Trials on Intervention arm: Text Message Intervention
-
St. Louis UniversityEpharmix, Inc.TerminatedShort Bowel SyndromeUnited States
-
Dokuz Eylul UniversityActive, not recruitingType 2 Diabetes Mellitus (T2DM) | Patient Activation | Diabetes Self-management | Diabetes Mellitus (DM)Turkey
-
University of PennsylvaniaCompletedGestational Diabetes | Diabetes in Pregnancy | Texting InterventionsUnited States
-
Massachusetts General HospitalCompletedHypertension | Type2 Diabetes | HyperlipemiaUnited States
-
Samanta Winck MadrugaUnknown
-
Boston UniversityCompletedEating DisordersUnited States
-
Universidad Peruana Cayetano HerediaCompleted
-
University of PennsylvaniaCompletedColonoscopy | Adherence, Patient | Text MessagingUnited States
-
Boston Medical CenterCompletedAmbulation DifficultyUnited States
-
Emory UniversityNational Cancer Institute (NCI)CompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States